Travere Therapeutics Inc (TVTX)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Travere Therapeutics Announces Inducement Grants to New Employees
Travere Therapeutics* Licensing Agreement Brings Sparsentan to East Asia and Southeast Asia Regions
Travere Therapeutics Sets New Course to Revolutionize Classical Homocystinuria Treatment
Travere Therapeutics Inc Beats Expectations, Turns Revenue Woes into Positive Earnings
Lackluster results at Travere Therapeutics Inc in the fiscal time-frame ending December 31 2022
The Diminishing Returns have expanded at the company in the third quarter of 2022